Uniqure N.V. current report, Q1 FY2014

Business Context and Reporting Period

uniQure N.V., a foreign private issuer, filed Form 6-K on March 26, 2014. The filing serves to distribute a press release announcing the Company's financial results for the fiscal year ended December 31, 2013.

Key Financial Metrics

The filing text provided does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document acts solely as a cover for the attached press release (Exhibit 99.1) which contains the actual financial figures.

Material Changes

The filing text does not provide a clear value or description of material changes versus the prior comparable period. Such details are contained within the referenced press release.

Guidance, Outlook, and Risks

The filing text does not provide specific guidance, management commentary, risks, contingencies, or unusual items. The document references a press release for the announcement of results but does not include the content of that release.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated March 26, 2014) for actual financial performance data.
  • Verify the specific revenue and net loss figures for the year ended December 31, 2013.
  • Confirm cash position and burn rate details not present in this summary filing.
  • Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.